Darifenacin
| Use attributes for filter ! | |
| Molar mass | 426. 55 g/mol |
|---|---|
| CAS ID | 133099-04-4 |
| Protein binding | 98% |
| Formula | C28H30N2O2 |
| Trade name | Enablex |
| Elimination half-life | 13 to 19 hours |
| Music groups | Solifenacin |
| Tolterodine | |
| Oxybutynin | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2072187 |
About Darifenacin
Darifenacin is a medication used to treat urinary incontinence. It was discovered by scientists at the Pfizer research site in Sandwich, UK under the identifier UK-88,525 and used to be marketed by Novartis. In 2010 the US rights were sold to Warner Chilcott for 400 million US$.